Hideaki Hiratsuka
Mitsubishi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideaki Hiratsuka.
Toxicologic Pathology | 2010
Hideomi Uchida; Yoshimasa Kurata; Hideaki Hiratsuka; Takashi Umemura
Itai-itai disease (IID) of humans is one of the most severe forms of chronic cadmium (Cd) intoxication. Itai-itai disease occurs mainly in post-menopausal women and is characterized by osteoporosis with osteomalacia, renal tubular disorder, and renal anemia. Some researchers insist the major cause of IID is not Cd, but rather malnutrition, especially hypovitaminosis D. We administrated a low concentration of Cd chloride intravenously to ovariectomized female rats that were fed a vitamin D–deficient diet or a normal diet for fifty weeks. The vitamin D–deficient diet decreased serum concentration of vitamin D, but it did not affect the metabolism of the kidney or bone. Cadmium treatment alone induced a decrease in serum concentration of vitamin D, as well as renal dysfunction, renal anemia, and abnormal bone metabolism. Osteoporosis with osteomalacia, tubular nephropathy, fibrous osteodystrophy, and bone marrow hyperplasia occurred following Cd treatment. In rats treated with Cd and administered a vitamin D–deficient diet, the toxic effects of Cd on kidney, bone, and hematopoiesis were enhanced in comparison to rats treated with Cd and a normal diet. The present experiment demonstrated that hypovitaminosis D did not evoke morphologic features of IID in humans but did enhance Cd-induced toxicity in the rat model of this disease.
Toxicologic Pathology | 1996
Osamu Katsuta; Hideaki Hiratsuka; Junko Matsumoto; Minoru Tsuchitani; Takashi Umemura
The effects of cadmium chloride on both incisor and molar teeth of ovariectomized female rats were studied histopathologically. The rats were injected intravenously with the compound at doses of 1.0 and 2.0 mg/kg, 5 days/wk. Six rats per group were sacrificed at 4, 8, and 13 wk. Discoloration of the incisors was observed in the rats of the 2.0-mg/kg group from 8 wk. Histopathologic examination of the incisor demonstrated decreased iron-containing pigment in ameloblasts and destruction of the enamel organ. These changes were accompanied with accumulation of cadmium and loss of iron in the teeth. Necrosis of the dental pulp occurred from the coronal end of both the incisor and molar teeth extended to the apical, deep portion of the teeth. The dental pulp of the molar teeth, which is shorter than that of the incisor, was mildly affected by cadmium intoxication. These findings suggested that intradental ischemia due to cadmium toxicity may have contributed to the development of the pulpal necrosis.
International Journal of Experimental Pathology | 2001
Yoshimasa Kurata; Osamu Katsuta; Hideaki Hiratsuka; Minoru Tsuchitani; Takashi Umemura
The aim of the present study was to clarify the therapeutic effects of 1α, 25[OH]2 vitamin D3 (calcitriol) pulse injection on bone lesions induced in a rat model of chronic cadmium toxicosis. Ovariectomized (OVX) and control‐operated (sham‐OVX) rats were given repeated intravenous injections of 0.5 mg/kg/day CdCl2 for 70 weeks. The rats were then treated intravenously with 0.02 μg/kg/day calcitriol 3 days per week for 8 weeks. CdCl2 treatment induced increases in osteoid volumes of the femur cortex and trabecula. This change was accompanied by an increase in the volume of iron deposition at the mineralization front of the trabeculae and a reduction in mineral density. Abnormalities of bone metabolic parameters, which were increases in the blood calcium, inorganic phosphorous, bone‐specific alkaline phosphatase, parathyroid hormone (PTH) and osteocalcin levels, and in the urine deoxypyridinoline (D‐PYR) level, were also induced. Calcitriol treatment increased the blood calcium and inorganic phosphorous levels, and reduced the blood PTH level. Decreases in blood tartrate‐resistant acid phosphatase and urine d‐PYR levels were also induced indicating that bone resorption was suppressed. The findings indicated that the increased osteoid volume of the cortex and Fe‐deposition volume of the trabecula were improved. These effects or improvements were observed in the sham‐OVX rats but not in the OVX rats.
Veterinary Pathology | 2014
Yoshimasa Kurata; Osamu Katsuta; Takuya Doi; Takeshi Kawasuso; Hideaki Hiratsuka; Minoru Tsuchitani; Takashi Umemura
In an attempt to establish a primate model of chronic cadmium toxicosis, we ovariectomized cynomolgus monkeys and treated them with CdCl2 by repeated intravenous injections for 13 to 15 months. The animals showed normocytic-normochromic anemia. The cadmium treatment resulted in increases of urinary enzyme activity indicative of renal tubular degeneration. Histopathology of the kidney revealed renal proximal tubular atrophy accompanied by interstitial fibrosis. Decreased bone mineral density was evident in the trabecular and cortical zones of the lumbar vertebra and femur, with osteoid accumulation around the trabeculae and Haversian canals. Iron deposition at the mineralization front and osteoclasts hyperplasia were indicative of impairment of bone mineralization and an increase of resorption. Blood inorganic phosphorus and 1α,25(OH)2 vitamin D3 levels decreased and urinary deoxypyridinoline level increased in cadmium-treated animals. The renal and bone lesions closely resemble those of itai-itai disease patients, the most severe case of cadmium toxicosis in terms of clinical chemistry and histopathology. Thus, ovariectomized monkeys chronically exposed to cadmium can serve as a primate itai-itai disease model, which is beneficial for developing novel therapeutic methods, investigating the mechanisms of the renal and bone lesions, and establishing more clearly defined criteria for diagnosing the disease.
Toxicology and Applied Pharmacology | 1996
Hideaki Hiratsuka; Osamu Katsuta; Naoto Toyota; Minoru Tsuchitani; Takashi Umemura; Fumiaki Marumo
Toxicology and Applied Pharmacology | 1994
Osamu Katsuta; Hideaki Hiratsuka; J. Matsumoto; H. Iwata; Naoto Toyota; Minoru Tsuchitani; Takashi Umemura; Fumiaki Marumo
Toxicology and Applied Pharmacology | 1997
Hideaki Hiratsuka; Osamu Katsuta; Naoto Toyota; Minoru Tsuchitani; Takashi Akiba; Fumiaki Marumo; Takashi Umemura
Toxicology and Applied Pharmacology | 1999
Hideaki Hiratsuka; Shin-ichi Satoh; Masahiko Satoh; Motohiro Nishijima; Yasutaka Katsuki; Jin Suzuki; Jun-ichi Nakagawa; Masami Sumiyoshi; Makoto Shibutani; Kunitoshi Mitsumori; Toshiko Tanaka-Kagawa; Masanori Ando
Toxicology and Applied Pharmacology | 1993
Osamu Katsuta; Hideaki Hiratsuka; J. Matsumoto; Minoru Tsuchitani; Takashi Umemura; Fumiaki Marumo
Archives of Toxicology | 2000
Makotoy Shibutani; Kunitoshi Mitsumori; Naoko Niho; Shin-ichi Satoh; Hideaki Hiratsuka; Masahiko Satoh; Masami Sumiyoshi; Motohiro Nishijima; Yasutaka Katsuki; Jin Suzuki; Jun-ichi Nakagawa; Masanori Ando